These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27494260)

  • 1. Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose.
    Zhang X; An J; Tu A; Liang X; Cui F; Zheng H; Tang Y; Liu J; Wang X; Zhang N; Li H
    Hum Vaccin Immunother; 2016 Sep; 12(9):2322-6. PubMed ID: 27494260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction.
    Wang X; Xu W; Hu Y; Yao H; Xu L; Ma M; Zhang Y; Wang Y
    Hum Vaccin Immunother; 2023 Aug; 19(2):2227549. PubMed ID: 37357804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine.
    Zhang Z; Zhu X; Hu Y; Liang M; Sun J; Song Y; Yang Q; Ji H; Zeng G; Song L; Chen J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28319454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response to one booster dose of inactivated hepatitis A vaccine in college students].
    Liao Z; Feng XW; Liu XE; Zhou YS; Wen HR; Peng SH; Zhang YX; Xu B; Zhuang H; Chen HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):625-628. PubMed ID: 28651399
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction.
    Wang Y; Qi Y; Xu W; Hu Y; Wang L; Yu Y; Jiang Z; Xia J; Zeng G; Wang Y
    Hum Vaccin Immunother; 2020 Oct; 16(10):2559-2564. PubMed ID: 32040376
    [No Abstract]   [Full Text] [Related]  

  • 11. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV
    Thuluva S; Matur R; Tsa K; Gv SR
    Vaccine; 2021 Dec; 39(49):7166-7174. PubMed ID: 34763950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
    Wang X; Meng Z; Li R
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Immunogenicity Between Inactivated and Live Attenuated Hepatitis A Vaccines Among Young Adults: A 3-Year Follow-up Study.
    Liu XE; Chen HY; Liao Z; Zhou Y; Wen H; Peng S; Liu Y; Li R; Li J; Zhuang H
    J Infect Dis; 2015 Oct; 212(8):1232-6. PubMed ID: 25969561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H; Kumavat V; Singh T; Versteilen A; Sarnecki M
    Hum Vaccin Immunother; 2014; 10(7):2089-97. PubMed ID: 25424821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A immunisation in persons not previously exposed to hepatitis A.
    Irving GJ; Holden J; Yang R; Pope D
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD009051. PubMed ID: 22786522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix®) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen®) for Japanese travelers to endemic countries.
    Fukushima S; Kiyohara T; Ishii K; Nakano T; Hamada A
    Vaccine; 2017 Nov; 35(47):6412-6415. PubMed ID: 29029942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
    Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A
    Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.